James S Kaufman

Summary

Country: USA

Publications

  1. ncbi request reprint Randomized controlled trial of clopidogrel plus aspirin to prevent hemodialysis access graft thrombosis
    James S Kaufman
    Department of Veterans Affairs Boston Healthcare System and Department of Medicine, Boston University School of Medicine, Boston, Massachusetts 02130, USA
    J Am Soc Nephrol 14:2313-21. 2003
  2. doi request reprint Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial
    Laura M Dember
    Boston University, School of Medicine, Renal Section, EBRC 504, 650 Albany St, Boston, Massachusetts 02118, USA
    JAMA 299:2164-71. 2008
  3. ncbi request reprint Randomized controlled trial of prophylactic repair of hemodialysis arteriovenous graft stenosis
    Laura M Dember
    Renal Sections of Boston University School of Medicine, Boston, Massachusetts, USA
    Kidney Int 66:390-8. 2004
  4. ncbi request reprint Age affects outcomes in chronic kidney disease
    ANN M O'HARE
    Department of Medicine, University of Washington, VA Puget Sound Healthcare System, Division of Nephrology, Building 100 Room 5B113, 1660 S Columbian Way, Seattle, WA 98108, USA
    J Am Soc Nephrol 18:2758-65. 2007
  5. doi request reprint Predialysis nephrology care and costs in elderly patients initiating dialysis
    Kevin T Stroupe
    Center for Management of Complex Chronic Care, Hines VA Hospital, Hines, IL 60141 5151, USA
    Med Care 49:248-56. 2011
  6. ncbi request reprint Adherence to guidelines for ESRD anemia management
    Denise M Hynes
    Midwest Center for Health Services and Policy Research, Cooperative Studies Program Coordinating Center, Edward Hines Jr Veterans Affairs Hospital, Hines, IL 60141, USA
    Am J Kidney Dis 47:455-61. 2006
  7. ncbi request reprint Current guidelines for using angiotensin-converting enzyme inhibitors and angiotensin II-receptor antagonists in chronic kidney disease: is the evidence base relevant to older adults?
    ANN M O'HARE
    Division of Nephrology, Department of Medicine, University of Washington and Veterans Affairs Puget Sound Health Care System, Seattle, Washington 98108, USA
    Ann Intern Med 150:717-24. 2009
  8. doi request reprint The Central American epidemic of CKD
    Daniel E Weiner
    Division of Nephrology, Tufts Medical Center and Tufts University School of Medicine, Boston, Massachusetts 02111, USA
    Clin J Am Soc Nephrol 8:504-11. 2013
  9. pmc Homocysteine lowering and cognition in CKD: the Veterans Affairs homocysteine study
    Christopher B Brady
    Geriatric Research, Education, and Clinical Center, Veterans Affairs Boston Healthcare System, Boston, MA 02130, USA
    Am J Kidney Dis 54:440-9. 2009
  10. pmc Chronic kidney disease in Nicaragua: a qualitative analysis of semi-structured interviews with physicians and pharmacists
    Oriana Ramírez-Rubio
    Boston University School of Public Health, Boston, MA, USA
    BMC Public Health 13:350. 2013

Detail Information

Publications16

  1. ncbi request reprint Randomized controlled trial of clopidogrel plus aspirin to prevent hemodialysis access graft thrombosis
    James S Kaufman
    Department of Veterans Affairs Boston Healthcare System and Department of Medicine, Boston University School of Medicine, Boston, Massachusetts 02130, USA
    J Am Soc Nephrol 14:2313-21. 2003
    ..22 to 1.26; P = 0.14). In the hemodialysis population, therapy with aspirin and clopidogrel was associated with a significantly increased risk of bleeding and probably would not result in a reduced frequency of graft thrombosis...
  2. doi request reprint Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial
    Laura M Dember
    Boston University, School of Medicine, Renal Section, EBRC 504, 650 Albany St, Boston, Massachusetts 02118, USA
    JAMA 299:2164-71. 2008
    ..Small, inconclusive trials have suggested that antiplatelet agents may reduce thrombosis of new fistulas...
  3. ncbi request reprint Randomized controlled trial of prophylactic repair of hemodialysis arteriovenous graft stenosis
    Laura M Dember
    Renal Sections of Boston University School of Medicine, Boston, Massachusetts, USA
    Kidney Int 66:390-8. 2004
    ..The present study is a randomized trial comparing prophylactic repair of AV graft stenosis with repair at the time of thrombosis...
  4. ncbi request reprint Age affects outcomes in chronic kidney disease
    ANN M O'HARE
    Department of Medicine, University of Washington, VA Puget Sound Healthcare System, Division of Nephrology, Building 100 Room 5B113, 1660 S Columbian Way, Seattle, WA 98108, USA
    J Am Soc Nephrol 18:2758-65. 2007
    ..73 m(2). In conclusion, age is a major effect modifier among patients with an eGFR of <60 ml/min per 1.73 m(2), challenging us to move beyond a uniform stage-based approach to managing CKD...
  5. doi request reprint Predialysis nephrology care and costs in elderly patients initiating dialysis
    Kevin T Stroupe
    Center for Management of Complex Chronic Care, Hines VA Hospital, Hines, IL 60141 5151, USA
    Med Care 49:248-56. 2011
    ..Access to nephrology care before initiation of chronic dialysis is associated with improved outcomes after initiation. Less is known about the effect of predialysis nephrology care on healthcare costs and utilization...
  6. ncbi request reprint Adherence to guidelines for ESRD anemia management
    Denise M Hynes
    Midwest Center for Health Services and Policy Research, Cooperative Studies Program Coordinating Center, Edward Hines Jr Veterans Affairs Hospital, Hines, IL 60141, USA
    Am J Kidney Dis 47:455-61. 2006
    ..Because reimbursement for erythropoietin differs for federal versus private-sector dialysis centers, we hypothesized different use patterns by facility type...
  7. ncbi request reprint Current guidelines for using angiotensin-converting enzyme inhibitors and angiotensin II-receptor antagonists in chronic kidney disease: is the evidence base relevant to older adults?
    ANN M O'HARE
    Division of Nephrology, Department of Medicine, University of Washington and Veterans Affairs Puget Sound Health Care System, Seattle, Washington 98108, USA
    Ann Intern Med 150:717-24. 2009
    ....
  8. doi request reprint The Central American epidemic of CKD
    Daniel E Weiner
    Division of Nephrology, Tufts Medical Center and Tufts University School of Medicine, Boston, Massachusetts 02111, USA
    Clin J Am Soc Nephrol 8:504-11. 2013
    ....
  9. pmc Homocysteine lowering and cognition in CKD: the Veterans Affairs homocysteine study
    Christopher B Brady
    Geriatric Research, Education, and Clinical Center, Veterans Affairs Boston Healthcare System, Boston, MA 02130, USA
    Am J Kidney Dis 54:440-9. 2009
    ..Whether treatment with high-dose B vitamins to decrease high tHcy levels improves cognition in persons with kidney disease is unknown...
  10. pmc Chronic kidney disease in Nicaragua: a qualitative analysis of semi-structured interviews with physicians and pharmacists
    Oriana Ramírez-Rubio
    Boston University School of Public Health, Boston, MA, USA
    BMC Public Health 13:350. 2013
    ..This study examines health professionals´ perceptions regarding etiology of these conditions and their treatment approaches, including use of potentially nephrotoxic medications...
  11. ncbi request reprint Value of static venous pressure for predicting arteriovenous graft thrombosis
    Laura M Dember
    Renal Sections, Boston University School of Medicine and VA Boston Healthcare System, Boston, Massachusetts, USA
    Kidney Int 61:1899-904. 2002
    ..However, it is not known how well static venous pressure elevation predicts subsequent AV graft thrombosis...
  12. doi request reprint Chronic kidney disease associated with environmental toxins and exposures
    Peter Soderland
    Renal Section, Boston University School of Medicine, Boston, MA, USA
    Adv Chronic Kidney Dis 17:254-64. 2010
    ..The effects of these agents may be modulated by genetic susceptibility and other comorbid conditions and may lead to the development of acute and CKD. In this article, we present environmental factors that are associated with CKD...
  13. ncbi request reprint Design of the Dialysis Access Consortium (DAC) Clopidogrel Prevention of Early AV Fistula Thrombosis Trial
    Laura M Dember
    Renal Section, Boston University School of Medicine, MA 02118 USA
    Clin Trials 2:413-22. 2005
    ..The autogenous arteriovenous fistula created by direct connection of native artery to vein is the recommended vascular access for hemodialysis. However, it fails frequently due to clotting after surgery...
  14. ncbi request reprint Design of the Dialysis Access Consortium (DAC) Aggrenox Prevention Of Access Stenosis Trial
    Bradley S Dixon
    Nephrology Division, Veterans Affairs Medical Center and University of Iowa School of Medicine, Iowa City 52242 1081, USA
    Clin Trials 2:400-12. 2005
    ..The Dialysis Access Consortium (DAC) Aggrenox Prevention of Access Stenosis Trial tests the hypothesis that Aggrenox (containing dipyridamole and aspirin) can prevent stenosis and prolong survival of arteriovenous grafts...
  15. ncbi request reprint Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial
    Rex L Jamison
    Veterans Affairs Palo Alto Health Care Systems and Division of Nephrology, Department of Medicine, Stanford University School of Medicine, Stanford, California 94304, USA
    JAMA 298:1163-70. 2007
    ..Folic acid and B vitamins decrease homocysteine levels in this population but whether they lower mortality is unknown...
  16. ncbi request reprint Potential cost savings of erythropoietin administration in end-stage renal disease
    Denise M Hynes
    Department of Veterans Affairs Cooperative Studies Program Coordinating Center, Hines, Edward G Hines, JR VA Hospital, Illinois 60141, USA
    Am J Med 112:169-75. 2002
    ..Since epoetin is expensive, optimizing the therapeutic effect of epoetin using a strategy that includes subcutaneous administration could lead to substantial cost savings...